Contribute Try STAT+ Today

In an unexpected development, two members of the Sackler family, which controls Purdue Pharma, will testify at a House hearing on Thursday about the role the company played in fueling the opioid crisis.

Former Purdue board members David Sackler and Kathe Sackler, along with Purdue chief executive officer Craig Landau, will appear virtually at the hearing scheduled by the Committee on Oversight and Reform. The committee, which investigated the drug maker and the extensive involvement of various Sackler family members in decision making, had threatened to issue subpoenas if they did not appear.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.